Patents applications published 27 October 2010
Selected patent applications from the weekly European Patents Bulletin
- Synthesis of resocylic acid lactones useful as therapeutic agents
University de Strasbourg; Wissinger, Nicolas; Barleunga, Sofia; Karplus, Martin 2242359*
- Doxorubicin adjuvants to reduce toxicity and methods for using the same
Tosk 2242360*
- IAP inhibitors
Tetralogic Pharmaceuticals 2242362*
- Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane and novel salt forms of the racemate and enantiomers
Targacept 2242364*
- Combinations of anilinopyrimidines and pyrion compounds
Janssen Pharmaceutica 2242365*
- REL inhibitors and methods of use thereof
The Trustees of the University of Pennsylvania 2242367*
- Poloxamer foamable pharmaceutical compsns with active agents and/or therapeutic cells and uses
Foamix 2242476*
- Topically active steroids for use in interstitial pulmonary fibrosis
Soligenix 2242477*
- Topical compsn for delivery of proteins and peptides
Kringle Pharma 2242478*
- Counter-pressure filtration of proteins
Baxter International 2242479*
- Platelet-activating factor (PAF) analogues and uses thereof
Vascular Biogenics 2242480*
- Article and method for focused delivery of therapeutic and/or diagnostic materials
Armark Authentication Technologies 2242481*
- Anti-retroviral combination
Cipla 2242482*
- Raloxifene compsn
Synthon 2242483*
- Sustained release dosage form for lubricating an oral cavity
Bennes 2242484*
- Oral controlled release tablet
Sun Pharma Advanced Research 2242485*
- Encapsulation of vitamin C into water soluble dendrimers
Centre National de la Recherche Scientifique - CNRS 2242486*
- A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist
Sharma, Anant 2242487*
- Amino acid derivatives used as pharmaceutical substances
Dritte Patentportfolio Beteiligungsgesellschaft 2242488*
- Combination therapeutic compsns and method of use
Messadek, Jallal 2242489*
- Novel use of 3,3’-diindolylmethane
DSM IP Assets 2242491*
- Antitumoral agents with a benzo-phenanthridine structure and formulations containing them
Indena 2242492*
- Derivations of GEFITINIB
Concert Pharmaceuticals 2242493*
- Methods of making low molecular weight heparin compsns
Momenta Pharmaceuticals 2242494*
- Use of antimicrobial polymers for re-sensitisation of micro-organisms upon emergence of resistance to anti-microbial agents
Technion Research & Development Foundation 2242495*
- Methods for in vitro maturation of ovarian follicles
Liu, Kui 2242496*
- Diabetes prophylaxis and treatment remedy and a method of getting it
Zdrave-Tera 2242497*
- Synergistic antiparasitic compsns and screening methods
Tyratech 2242498*
- Compsns for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer
Indena 2242499*
- Use of an active agent derived from cyperus esculentus for the cutaneous anti-ageing action thereof
Société Industrielle Limousine d’Application Biologique Dite SILAB 2242500*
- Therapeutic inhibitors of PAI-1 function methods of their use
Intrexon 2242501*
- Synthesis of macrocyclic cancer chemotherapy agents and methods of use
Purdue Research Foundation 2242502*
- Therapeutic peptidomimetic macrocycles
Aileron Therapeutics 2242503*
- Therapeutic compsns for treatment of ocular inflammatory disorders
Schepens Eye Research Institute 2242504*
- Glycoconjugation of polypeptides using oligosaccharlytransferases
BiogeneriX 2242505*
- Method of treating erythropoietin hyporesponsive anaemias
Cantocor Ortho Biotech 2242506*
- Formulation and method for the prevention and treatment of skeletal manifestation of Gaucher’s disease
Erytech Pharma 2242507*
- Pharmaceutical compsns containing the enzyme cyprosin, an aspartic peptidase from Cynara cardunculus and its inclusion in antitumour formulations
Ecbio, Investigaçäo e Desenvolvimento em Biotecnologia 2242508*
- Biomarker for selecting patients and related methods
Transgene 2242509*
- Virus-like particles as vaccines for paramyxovirus
University of Massachusetts Medical School 2242510*
- Method for manipulating phagocytosis mediated by CD47
The Board of Trustees of the Leland Stanford Junior University 2242512*
- Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders
Hadasit Medical Research Services & Development; The Brigham and Women’s Hospital 2242513*
- Intralymphatic chemotherapy drug carriers
University of Kansas 2242514*
- Process for preparing a pharmaceutical formulation of contrast agents
Guerbet 2242515*
- Methods and compsns for detection f bacteria and treatment of diseases and disorders
Genelux 2242516*
- Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficiency
Nanospectra Biosciences 2242539*
- SP5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments
Sanofi-Aventis 2242740*
- Cycloalkyl-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
Bayer Schering Pharma AG 2242741*
- Organic compounds
Novartis 2242742*
- Aminopyrazole derivatives
Actelion Pharmaceuticals 2242743*
- Process for working up ionic liquids
BASF 2242744*
- Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof
Sanofi-Aventis 2242745*
- Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
Sanofi-Aventis 2242746*
- Substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds, and use thereof
Sanofi-Aventis 2242747*
- Therapeutic disulphide compounds for treating pain and diabetes
Allergan 2242748*
- Novel pyridinines and pyridazinones
F Hoffmann-La Roche 2242749*
- Conformationally restricted biphenyl derivatives for use as hepatitis C virus inhibitors
Bristol-Myers Squibb 2242750*
- Heterocyclic derivatives as hepatitis C virus inhibitors
Bristol-Myers Squibb 2242751*
- Imidazolyl biphenyl imidazoles as hepatitis C virus inhibitors
Bristol-Myers Squibb 2242752*
- Oxazolidine and theizolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
Allergan 2242753*
- Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
NeuroSearch 2242754*
- Pyrrolopyridines as kinase inhibitors
Array Biopharma 2242755*
- Pyrrolopyrimidines as pyrrolopyridines
Novartis 2242756*
- Pyrazolopyridines as kinase inhibitors
Array Biopharma 2242757*
- Crystalline form of abacavir that is essentially free of solvent
Esteve Quimica 2242758*
- Compounds
AstraZeneca; Pulmagen Therapeutics (Synergy) 2242759*
- Sulphonated organophosphine compounds and use in hydroformulation processes
Dow Global Technologies 2242760*
- Method of mycotoxin detection
Neoventures Biotechnology 2242761*
- Enhanced purification of antibodies and antibody fragments by apatite chromatography
Bio-Rad Laboratories 2242762*
- Anti-bacterial compsns
Novartis 2242763*
- Methods and compsns related to internalising RGD peptides
Burnham Institute for Medical Research 2242764*
- Short fatty acid tail polymyxin derivatives and uses thereof
Northern Antibiotics 2242765*
- Process for the production of biologically active HIV-1 TAT protein
Istituto Superiore di Sanità; Universita Degli Studi di Urbino 2242766*
- A method of obtaining purified heterologous insulins expressed in yeast
Biocon 2242767*
- Cross-neutralising human monoclonal antibodies to SARS-VOC and methods of use thereof
Humabs 2242768*
- Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
Synovex 2242769*